ATE255886T1 - Direktkomprimierte partikel für feste darreichungsformen - Google Patents
Direktkomprimierte partikel für feste darreichungsformenInfo
- Publication number
- ATE255886T1 ATE255886T1 AT01925043T AT01925043T ATE255886T1 AT E255886 T1 ATE255886 T1 AT E255886T1 AT 01925043 T AT01925043 T AT 01925043T AT 01925043 T AT01925043 T AT 01925043T AT E255886 T1 ATE255886 T1 AT E255886T1
- Authority
- AT
- Austria
- Prior art keywords
- solid dosage
- dosage forms
- compressed particles
- direct compressed
- copolymer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/559,687 US6623756B1 (en) | 2000-04-27 | 2000-04-27 | Directly compressed solid dosage articles |
PCT/US2001/012400 WO2001082894A2 (en) | 2000-04-27 | 2001-04-17 | Directly compressed solid dosage particles |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE255886T1 true ATE255886T1 (de) | 2003-12-15 |
Family
ID=24234605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01925043T ATE255886T1 (de) | 2000-04-27 | 2001-04-17 | Direktkomprimierte partikel für feste darreichungsformen |
Country Status (13)
Country | Link |
---|---|
US (1) | US6623756B1 (de) |
EP (1) | EP1276466B1 (de) |
JP (1) | JP2003531848A (de) |
CN (1) | CN1195498C (de) |
AT (1) | ATE255886T1 (de) |
BR (1) | BR0110287A (de) |
CA (1) | CA2407140A1 (de) |
DE (1) | DE60101468T2 (de) |
ES (1) | ES2211796T3 (de) |
IL (2) | IL152461A0 (de) |
MX (1) | MXPA02010437A (de) |
WO (1) | WO2001082894A2 (de) |
ZA (1) | ZA200208571B (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6955821B2 (en) | 2000-04-28 | 2005-10-18 | Adams Laboratories, Inc. | Sustained release formulations of guaifenesin and additional drug ingredients |
US7838032B2 (en) * | 2000-04-28 | 2010-11-23 | Reckitt Benckiser Inc. | Sustained release of guaifenesin |
US8012504B2 (en) * | 2000-04-28 | 2011-09-06 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US7985420B2 (en) * | 2000-04-28 | 2011-07-26 | Reckitt Benckiser Inc. | Sustained release of guaifenesin combination drugs |
US6623754B2 (en) | 2001-05-21 | 2003-09-23 | Noveon Ip Holdings Corp. | Dosage form of N-acetyl cysteine |
US20030012820A1 (en) * | 2001-06-12 | 2003-01-16 | Upadhyay Ajay Hasmukhlal | Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom |
US6705028B2 (en) * | 2001-09-12 | 2004-03-16 | Honda Giken Kogyo Kabushiki Kaisha | Self-propelled snowplow vehicle |
US20040185016A1 (en) * | 2002-07-30 | 2004-09-23 | Popp Karl F | Compositions for treatment of hyperpigmentation and methods for making and using such compositions |
US20040219210A1 (en) * | 2003-05-01 | 2004-11-04 | Jian-Hwa Guo | Controlled release solid dosage nifedipine formulations |
US20050202079A1 (en) * | 2004-03-15 | 2005-09-15 | Mylan Pharmaceuticals Inc. | Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation |
US7704522B2 (en) | 2004-09-08 | 2010-04-27 | Clyde Morgan | Topical medicament |
US20070077297A1 (en) | 2004-09-30 | 2007-04-05 | Scolr Pharma, Inc. | Modified release ibuprofen dosage form |
FI20080346A0 (fi) * | 2008-05-09 | 2008-05-09 | Atacama Labs Oy | Prosessi lisäaineita sisältävän tabletin valmistamiseksi |
FI20080355A0 (fi) * | 2008-05-09 | 2008-05-09 | Atacama Labs Oy | Prosessi metforminia käsittävien tablettien valmistamiseksi |
FI20080353A0 (fi) * | 2008-05-09 | 2008-05-09 | Atacama Labs Oy | Prosessi erittäin korkean lääkepitoisuuden tabletin valmistamiseksi |
US7749537B2 (en) * | 2006-12-04 | 2010-07-06 | Scolr Pharma, Inc. | Method of forming a tablet |
CN101467988B (zh) * | 2007-12-27 | 2014-07-09 | 北京德众万全医药科技有限公司 | 一种含有氨酚伪麻的药用组合物及其制备方法 |
US20110284573A1 (en) * | 2008-12-17 | 2011-11-24 | Allan Dagsland | Method of providing a target dose, powder provider device and its use |
AR077712A1 (es) | 2009-08-05 | 2011-09-14 | Idenix Pharmaceuticals Inc | Inhibidores de serina proteasa macrociclica |
WO2011056764A1 (en) | 2009-11-05 | 2011-05-12 | Ambit Biosciences Corp. | Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles |
MY159958A (en) | 2009-12-18 | 2017-02-15 | Idenix Pharmaceuticals Inc | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
WO2011112689A2 (en) | 2010-03-11 | 2011-09-15 | Ambit Biosciences Corp. | Saltz of an indazolylpyrrolotriazine |
JP5933554B2 (ja) | 2010-09-01 | 2016-06-15 | アムビト ビオスシエンセス コルポラチオン | 光学活性のあるピラゾリルアミノキナゾリン及びその医薬組成物及び使用方法 |
CN103270030B (zh) | 2010-09-01 | 2016-01-20 | 埃姆比特生物科学公司 | 吡唑基氨基喹唑啉的氢溴酸盐 |
CA2819859A1 (en) | 2010-12-06 | 2012-06-14 | Follica, Inc. | Methods for treating baldness and promoting hair growth |
WO2012080050A1 (en) | 2010-12-14 | 2012-06-21 | F. Hoffmann-La Roche Ag | Solid forms of a phenoxybenzenesulfonyl compound |
EP2670396A1 (de) | 2011-01-31 | 2013-12-11 | Celgene Corporation | Pharmazeutische zusammensetzungen aus cytidinanaloga und anwendungsverfahren dafür |
WO2012109398A1 (en) | 2011-02-10 | 2012-08-16 | Idenix Pharmaceuticals, Inc. | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating hcv infections |
US20120252721A1 (en) | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
US9365556B2 (en) | 2012-03-16 | 2016-06-14 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
US20160229866A1 (en) | 2013-09-20 | 2016-08-11 | Idenix Pharmaceuticals Inc. | Hepatitis c virus inhibitors |
EP3114122A1 (de) | 2014-03-05 | 2017-01-11 | Idenix Pharmaceuticals LLC | Feste formen einer flaviviridae-virus-hemmerverbindung und salze davon |
CN106661027B (zh) | 2014-03-20 | 2019-12-24 | 卡佩拉医疗公司 | 苯并咪唑衍生物作为erbb酪氨酸激酶抑制剂用于治疗癌症 |
AU2015231202B9 (en) | 2014-03-20 | 2019-10-24 | Capella Therapeutics, Inc. | Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer |
US9546163B2 (en) | 2014-12-23 | 2017-01-17 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
WO2017062997A1 (en) | 2015-10-09 | 2017-04-13 | Reckitt Benckiser Llc | Pharmaceutical formulation |
JP2022520011A (ja) | 2019-01-24 | 2022-03-28 | ノヴォ ノルディスク アー/エス | ローラコンパクタおよびローラコンパクタを使用する乾式造粒の方法 |
JP2022547094A (ja) | 2019-09-06 | 2022-11-10 | ノヴォ ノルディスク アー/エス | 医薬組成物における使用のための顆粒の分別のための方法および機器 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2798053A (en) * | 1952-09-03 | 1957-07-02 | Goodrich Co B F | Carboxylic polymers |
CH606154A5 (de) * | 1974-07-02 | 1978-11-15 | Goodrich Co B F | |
US4267103A (en) * | 1978-12-07 | 1981-05-12 | The B. F. Goodrich Company | Solvent polymerization of carboxyl containing monomers |
DE3888520T2 (de) * | 1988-03-30 | 1994-07-21 | Japan Synthetic Rubber Co Ltd | Hoch vernetzte Polymerteilchen und Verfahren zur Herstellung derselben. |
WO1993023457A1 (en) * | 1992-05-09 | 1993-11-25 | Gel-Chem Limited | Conversion of powdered polymers |
US5288814A (en) * | 1992-08-26 | 1994-02-22 | The B. F. Goodrich Company | Easy to disperse polycarboxylic acid thickeners |
US5780055A (en) * | 1996-09-06 | 1998-07-14 | University Of Maryland, Baltimore | Cushioning beads and tablet comprising the same capable of forming a suspension |
-
2000
- 2000-04-27 US US09/559,687 patent/US6623756B1/en not_active Expired - Fee Related
-
2001
- 2001-04-17 MX MXPA02010437A patent/MXPA02010437A/es active IP Right Grant
- 2001-04-17 BR BR0110287-7A patent/BR0110287A/pt not_active Application Discontinuation
- 2001-04-17 DE DE60101468T patent/DE60101468T2/de not_active Expired - Lifetime
- 2001-04-17 AT AT01925043T patent/ATE255886T1/de not_active IP Right Cessation
- 2001-04-17 IL IL15246101A patent/IL152461A0/xx active IP Right Grant
- 2001-04-17 ES ES01925043T patent/ES2211796T3/es not_active Expired - Lifetime
- 2001-04-17 EP EP01925043A patent/EP1276466B1/de not_active Expired - Lifetime
- 2001-04-17 WO PCT/US2001/012400 patent/WO2001082894A2/en active IP Right Grant
- 2001-04-17 CN CNB018086330A patent/CN1195498C/zh not_active Expired - Fee Related
- 2001-04-17 CA CA002407140A patent/CA2407140A1/en not_active Abandoned
- 2001-04-17 JP JP2001579769A patent/JP2003531848A/ja not_active Withdrawn
-
2002
- 2002-10-23 ZA ZA200208571A patent/ZA200208571B/en unknown
- 2002-10-24 IL IL152461A patent/IL152461A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US6623756B1 (en) | 2003-09-23 |
MXPA02010437A (es) | 2003-04-25 |
JP2003531848A (ja) | 2003-10-28 |
ES2211796T3 (es) | 2004-07-16 |
BR0110287A (pt) | 2003-02-18 |
CN1426297A (zh) | 2003-06-25 |
IL152461A (en) | 2007-08-19 |
DE60101468D1 (de) | 2004-01-22 |
WO2001082894A3 (en) | 2002-02-21 |
WO2001082894A2 (en) | 2001-11-08 |
EP1276466A2 (de) | 2003-01-22 |
EP1276466B1 (de) | 2003-12-10 |
CN1195498C (zh) | 2005-04-06 |
CA2407140A1 (en) | 2001-11-08 |
ZA200208571B (en) | 2003-08-19 |
DE60101468T2 (de) | 2004-10-28 |
IL152461A0 (en) | 2003-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE255886T1 (de) | Direktkomprimierte partikel für feste darreichungsformen | |
EP2258345A3 (de) | Feste pharmazeutische Dosierform enthaltende eine HIV Protease Inhibitor feste Dispersion | |
MX9701465A (es) | Formulacion de acetaminofeno, de liberacion sostenida. | |
CA2385890A1 (en) | Controlled release compositions comprising nimesulide | |
EP1476138A4 (de) | Formulierungen mit modifizierter freisetzung von mindestens einer form von tramadol | |
NO981027L (no) | Bioadhesiv fast doseringsform | |
EP1211951A4 (de) | Verfahren zur herstellung eines pharmazeutischen kaugummis | |
UA42062C2 (uk) | Трифазова фармацевтична форма з постійним і контрольованим виділенням аморфного активного інгредієнта та спосіб її виготовлення | |
CA2102630A1 (en) | Pharmaceutical compositions of compacted medicaments | |
AU2003274681A1 (en) | Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release | |
CA2534056A1 (en) | Calcium carbonate granulation | |
AU6517596A (en) | Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors | |
MY169471A (en) | Controlled release preparation | |
UA84266C2 (uk) | Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування | |
MEP46008A (en) | Solid pharmaceutical formulations comprising telmisartan | |
WO2003103637A3 (en) | MODIFIED RELEASE MULTIPLE UNIT DRUG DELIVERY SYSTEMS | |
CA2445519A1 (en) | Method for manufacturing a low dose pharmaceutical composition | |
PT1195160E (pt) | Composições farmacêuticas de trimetazidina de libertação sustentada e método para a sua preparação | |
MXPA03008420A (es) | Forma farmaceutica solida oralmente dispersa. | |
MXPA06000332A (es) | Nueva composicion farmaceutica solida que comprende amisulprida. | |
WO2005115346A3 (en) | Pharmaceutical composition containing risperidone | |
DE69906982D1 (de) | Ibuprofen und domperidone enthaltende pharmazeutische zusammensetzungen | |
ES2174734A1 (es) | Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones. | |
CA2454449C (en) | Synergistic filler composition of pvp-va and silicified mycrocrystalline cellulose for tablet dosage form | |
WO2004043356A3 (en) | Coated dibasic calcium phosphate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1276466 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |